Paper·2026·Commentary
Paper·2024·Research article Landmark
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Frye RE, McCarty PJ, Werner BA, Scheck AC, Collins HL, Adelman SJ, Rossignol DA, Quadros EV
Journal of Personalized Medicine, 2024
In brief
Asks which blood marker predicts who responds to leucovorin, and points to the binding autoantibody.
A plain-language summary is not written yet
The foundation is writing summaries of its papers, starting with the most important ones. Until then, the citation and the link to the journal are below.
Citation
Frye RE, McCarty PJ, Werner BA, Scheck AC, Collins HL, Adelman SJ, Rossignol DA, Quadros EV. J Pers Med. 1 Jan 2024.
More on biomarkers
Paper·2025·Clinical trial
Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism: A Double-Blind Placebo-Controlled Cross-Over Trial
Paper·2025·Research article
De Novo Variants Predominate in Autism Spectrum Disorder
Paper·2024·Research article